Study highlights challenges of reducing risky drugs in Alzheimer’s patients

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer’s disease or related dementias by mailing patients, caregivers and their health care providers educational materials?

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup